139 related articles for article (PubMed ID: 27344927)
1. The differences between GesEPOC and GOLD.
Izquierdo Alonso JL
Arch Bronconeumol; 2016 Sep; 52(9):453-4. PubMed ID: 27344927
[No Abstract] [Full Text] [Related]
2. [Moving towards a new focus on COPD. The Spanish COPD Guidelines (GESEPOC)].
Grupo de Trabajo de GESEPOC
Arch Bronconeumol; 2011 Aug; 47(8):379-81. PubMed ID: 21757283
[No Abstract] [Full Text] [Related]
3. What was the impact of the Spanish COPD guidelines (GesEPOC) and how can they be improved?
Miravitlles M
Arch Bronconeumol; 2016 Jan; 52(1):1-2. PubMed ID: 26026686
[No Abstract] [Full Text] [Related]
4. [Position of the French Language Society of Pulmonology regarding the 2011 version of the GOLD document].
Roche N
Rev Mal Respir; 2012 May; 29(5):637-9. PubMed ID: 22682585
[No Abstract] [Full Text] [Related]
5. [Not Available].
Miravitlles M
Arch Bronconeumol; 2017 Jun; 53 Suppl 1():1. PubMed ID: 29029670
[No Abstract] [Full Text] [Related]
6. COPD (confusion over proper diagnosis) in the zone of maximum uncertainty.
Celli BR;
Eur Respir J; 2015 Nov; 46(5):1525-6. PubMed ID: 26521285
[No Abstract] [Full Text] [Related]
7. COPD (confusion over proper diagnosis) in the zone of maximum uncertainty.
Quanjer PH; Ruppel G; Brusasco V; Pérez-Padilla R; Fragoso CA; Culver BH; Swanney MP; Miller MR; Thompson B; Morgan M; Hughes M; Graham BL; Pellegrino R; Enright P; Buist AS; Burney P
Eur Respir J; 2015 Nov; 46(5):1523-4. PubMed ID: 26521284
[No Abstract] [Full Text] [Related]
8. Differences between GesEPOC and GOLD in 2017.
de-Torres JP; Marin JM
Arch Bronconeumol; 2017 Jun; 53(6):295-296. PubMed ID: 28506625
[No Abstract] [Full Text] [Related]
9. We must join forces in the battle against COPD.
Celli BR;
Eur Respir J; 2015 Nov; 46(5):1528. PubMed ID: 26521287
[No Abstract] [Full Text] [Related]
10. We must join forces in the battle against COPD.
Ostrem A; Williams S; Pinnock H;
Eur Respir J; 2015 Nov; 46(5):1526-8. PubMed ID: 26521286
[No Abstract] [Full Text] [Related]
11. The good COPD guidelines.
Bowie D;
Can Respir J; 2004; 11(1):15-6. PubMed ID: 15010727
[No Abstract] [Full Text] [Related]
12. COPD 2020 Guidelines - what is new and why?
Gupta N; Agrawal S; Chakrabarti S; Ish P
Adv Respir Med; 2020; 88(1):38-40. PubMed ID: 32153009
[No Abstract] [Full Text] [Related]
13. ACP updates guideline on diagnosis and management of stable COPD.
Armstrong C
Am Fam Physician; 2012 Jan; 85(2):204-5. PubMed ID: 22335223
[No Abstract] [Full Text] [Related]
14. [Recommendations of Polish Society of Lung Diseases about diagnosis and therapy of chronic obstructive pulmonary disease (COPD)].
Pierzchała W; Barczyk A; Górecka D; Sliwiński P; Zieliński J;
Pneumonol Alergol Pol; 2010; 78(5):318-47. PubMed ID: 20703997
[No Abstract] [Full Text] [Related]
15. [Chronic obstructive pulmonary disease in 2002].
León Jiménez A
Arch Bronconeumol; 2003 Aug; 39(8):377. PubMed ID: 12890410
[No Abstract] [Full Text] [Related]
16. Evolution of the GOLD documents for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Controversies and questions.
Yusen RD
Am J Respir Crit Care Med; 2013 Jul; 188(1):4-5. PubMed ID: 23815714
[No Abstract] [Full Text] [Related]
17. Do COPD treatment guidelines correctly address the treatment of smoking?
Jiménez Ruiz CA; Riesco Miranda JA
Arch Bronconeumol; 2016 Dec; 52(12):581-582. PubMed ID: 27259360
[No Abstract] [Full Text] [Related]
18. [Stage and prognosis of COPD].
Akashiba T
Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
[TBL] [Abstract][Full Text] [Related]
19. GOLD and the fixed ratio.
Vestbo J; Rodriguez-Roisin R
Eur Respir J; 2011 Aug; 38(2):481-2; author reply 482-4. PubMed ID: 21804170
[No Abstract] [Full Text] [Related]
20. 2014 GesEPOC and Systemic Steroids in chronic obstructive pulmonary disease (COPD) Exacerbation: An Update.
Marcos PJ; Huerta A; Márquez-Martín E
Arch Bronconeumol; 2015 Jul; 51(7):360. PubMed ID: 25022785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
